JP7390830B2 - 医薬活性化合物の苦味抑制剤及び苦味抑制方法 - Google Patents

医薬活性化合物の苦味抑制剤及び苦味抑制方法 Download PDF

Info

Publication number
JP7390830B2
JP7390830B2 JP2019165017A JP2019165017A JP7390830B2 JP 7390830 B2 JP7390830 B2 JP 7390830B2 JP 2019165017 A JP2019165017 A JP 2019165017A JP 2019165017 A JP2019165017 A JP 2019165017A JP 7390830 B2 JP7390830 B2 JP 7390830B2
Authority
JP
Japan
Prior art keywords
hydrochloride
cyclodextrin
moles
bitterness
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019165017A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021042159A (ja
JP2021042159A5 (enExample
Inventor
萌子 相沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Shokuhin Kako Co Ltd
Original Assignee
Nihon Shokuhin Kako Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Shokuhin Kako Co Ltd filed Critical Nihon Shokuhin Kako Co Ltd
Priority to JP2019165017A priority Critical patent/JP7390830B2/ja
Publication of JP2021042159A publication Critical patent/JP2021042159A/ja
Publication of JP2021042159A5 publication Critical patent/JP2021042159A5/ja
Priority to JP2023197093A priority patent/JP2024009146A/ja
Application granted granted Critical
Publication of JP7390830B2 publication Critical patent/JP7390830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019165017A 2019-09-11 2019-09-11 医薬活性化合物の苦味抑制剤及び苦味抑制方法 Active JP7390830B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019165017A JP7390830B2 (ja) 2019-09-11 2019-09-11 医薬活性化合物の苦味抑制剤及び苦味抑制方法
JP2023197093A JP2024009146A (ja) 2019-09-11 2023-11-21 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019165017A JP7390830B2 (ja) 2019-09-11 2019-09-11 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023197093A Division JP2024009146A (ja) 2019-09-11 2023-11-21 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Publications (3)

Publication Number Publication Date
JP2021042159A JP2021042159A (ja) 2021-03-18
JP2021042159A5 JP2021042159A5 (enExample) 2022-09-15
JP7390830B2 true JP7390830B2 (ja) 2023-12-04

Family

ID=74863742

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019165017A Active JP7390830B2 (ja) 2019-09-11 2019-09-11 医薬活性化合物の苦味抑制剤及び苦味抑制方法
JP2023197093A Pending JP2024009146A (ja) 2019-09-11 2023-11-21 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023197093A Pending JP2024009146A (ja) 2019-09-11 2023-11-21 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Country Status (1)

Country Link
JP (2) JP7390830B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230173533A (ko) * 2022-06-17 2023-12-27 주식회사 코아팜바이오 신규한 구강용해산 조성물
CN119564602A (zh) * 2025-02-08 2025-03-07 江苏长泰药业股份有限公司 一种盐酸托莫西汀口服溶液的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524513A (ja) 1998-09-15 2002-08-06 イーライ・リリー・アンド・カンパニー 持続痛の治療
JP2008543929A (ja) 2005-06-20 2008-12-04 カディラ・ヘルスケア・リミテッド デュロキセチンの調節放出型の投与製剤
WO2010150219A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
CN102579403A (zh) 2011-12-26 2012-07-18 天津市嵩锐医药科技有限公司 盐酸度洛西汀药物组合物
WO2018160043A1 (ko) 2017-03-03 2018-09-07 주식회사 씨티씨바이오 바레니클린 또는 이의 약학적으로 허용가능한 염의 포접 복합체를 포함하는 구강 투여용 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5535900A (en) * 1999-07-01 2001-01-22 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
US20040176466A1 (en) * 2001-08-08 2004-09-09 Allen Albert John Combination therapy for the treatment of neurological disorders
EP2583669A1 (en) * 2007-10-10 2013-04-24 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
US9855228B1 (en) * 2016-12-14 2018-01-02 Taho Pharmaceuticals Ltd. Oral solution comprising atomoxetine hydrochloride and methods thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524513A (ja) 1998-09-15 2002-08-06 イーライ・リリー・アンド・カンパニー 持続痛の治療
JP2008543929A (ja) 2005-06-20 2008-12-04 カディラ・ヘルスケア・リミテッド デュロキセチンの調節放出型の投与製剤
WO2010150219A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
CN102579403A (zh) 2011-12-26 2012-07-18 天津市嵩锐医药科技有限公司 盐酸度洛西汀药物组合物
WO2018160043A1 (ko) 2017-03-03 2018-09-07 주식회사 씨티씨바이오 바레니클린 또는 이의 약학적으로 허용가능한 염의 포접 복합체를 포함하는 구강 투여용 제제

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
日本醸造協会誌，1989年，84巻 4号，210-215

Also Published As

Publication number Publication date
JP2021042159A (ja) 2021-03-18
JP2024009146A (ja) 2024-01-19

Similar Documents

Publication Publication Date Title
JP5600747B2 (ja) 口腔内分散性製剤
CN101778626B (zh) 含有瑞巴派特的药物组合物
RU2671491C2 (ru) Комплексная гранулированная композиция, обладающая улучшенной стабильностью, включающая левоцетиризин и монтелукаст
JP6618099B2 (ja) 安定性に優れた固形製剤
JP2004520420A (ja) 味が遮蔽された製薬学的組成物
JP2024009146A (ja) 医薬活性化合物の苦味抑制剤及び苦味抑制方法
KR102650321B1 (ko) 액체 타시멜테온 제형 및 이의 사용 방법
CN102014904A (zh) 具有适口味道的去铁酮液体配制品
JP2003026575A (ja) 医薬組成物
KR20110015445A (ko) 아미노시클로헥산 유도체 및 시클로덱스트린의 복합체를 포함하는 제약 조성물
JP2011105694A (ja) オロパタジン経口固形組成物
JP2022132446A (ja) 低中毒性抗コリン作動性エステルのための方法および組成物
MX2012011445A (es) Formulacion de pelicula oral.
JP6590436B1 (ja) 安定性に優れた固形製剤
KR20210107038A (ko) 브라나플람의 경구 제형
CN114569742B (zh) 一种组合物及其制备方法和应用
CN114828829B (zh) 包含布洛芬和去氧肾上腺素的液体组合物
CN110314234A (zh) 瑞舒伐他汀钙树脂复合物及其组合物
JP6711875B2 (ja) マクロライド化合物の苦味抑制剤
JP2010053048A (ja) 苦味が緩和されたイルベサルタン含有医薬組成物
EP3563847B1 (en) Pharmaceutical composition
JP2020019731A (ja) アムロジピンベシル酸塩の苦味抑制剤
CN110167551A (zh) 医药组合物
HK1219882B (zh) 具有改善的稳定性的包含左西替利嗪和孟鲁司特的复合颗粒制剂
HK1058482B (en) Taste masked pharmaceutical compositions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220907

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230704

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231121

R150 Certificate of patent or registration of utility model

Ref document number: 7390830

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150